Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V De Stefano

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
Thrombosis and Haemostasis|May 1, 1996
Instrument effect on the activated protein C resistance plasma assay performed by a commercial kitV De Stefano, K Paciaroni, S Mastrangelo, et al.
Journal of Neurosurgical Sciences|June 1, 1996
Prognostic significance of nucleolar organizer regions in meningiomasV De Stefano, G Salvatore, A Monticelli, et al.
Gastroenterology|March 27, 2001
G20210A prothrombin gene mutation and other trombophilic polymorphisms in patients with portal or hepatic venous thrombosisP Madonna, V De Stefano, A Coppola, et al.
British Journal of Haematology|December 1, 1989
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old womanV De Stefano, L Teofili, B Rocca, et al.
Thrombosis Research|March 15, 1990
Mesenteric vein thrombosis in protein S congenital deficiencyV De Stefano, G Leone, L Teofili, et al.
Recenti Progressi in Medicina|February 1, 1986
[Procoagulant activity of the cerebrospinal fluid in patients with myeloproliferative diseases]L Pagano, R Marra, V De Stefano, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|February 1, 1997
Failure of fibrinolytic endoventricular treatment to prevent neonatal post-haemorrhagic hydrocephalus. A case-control trialR Luciano, F Velardi, C Romagnoli, et al.
British Journal of Haematology|February 13, 2001
The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or bothI Martinelli, P Bucciarelli, M Margaglione, et al.
European Journal of Histochemistry : EJH|January 1, 1997
APO-1/Fas receptor (CD95) is non-functionally expressed in acute promyelocytic leukemiasC Rumi, S Rutella, B M Lucia, et al.
British Journal of Haematology|July 1, 1988
Factor X Roma: a congenital factor X variant defective at different degrees in the intrinsic and the extrinsic activationV De Stefano, G Leone, R Ferrelli, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
Thrombosis and Haemostasis|May 1, 1996
Instrument effect on the activated protein C resistance plasma assay performed by a commercial kitV De Stefano, K Paciaroni, S Mastrangelo, et al.
Journal of Neurosurgical Sciences|June 1, 1996
Prognostic significance of nucleolar organizer regions in meningiomasV De Stefano, G Salvatore, A Monticelli, et al.
Gastroenterology|March 27, 2001
G20210A prothrombin gene mutation and other trombophilic polymorphisms in patients with portal or hepatic venous thrombosisP Madonna, V De Stefano, A Coppola, et al.
British Journal of Haematology|December 1, 1989
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old womanV De Stefano, L Teofili, B Rocca, et al.
Thrombosis Research|March 15, 1990
Mesenteric vein thrombosis in protein S congenital deficiencyV De Stefano, G Leone, L Teofili, et al.
Recenti Progressi in Medicina|February 1, 1986
[Procoagulant activity of the cerebrospinal fluid in patients with myeloproliferative diseases]L Pagano, R Marra, V De Stefano, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|February 1, 1997
Failure of fibrinolytic endoventricular treatment to prevent neonatal post-haemorrhagic hydrocephalus. A case-control trialR Luciano, F Velardi, C Romagnoli, et al.
British Journal of Haematology|February 13, 2001
The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or bothI Martinelli, P Bucciarelli, M Margaglione, et al.
European Journal of Histochemistry : EJH|January 1, 1997
APO-1/Fas receptor (CD95) is non-functionally expressed in acute promyelocytic leukemiasC Rumi, S Rutella, B M Lucia, et al.
British Journal of Haematology|July 1, 1988
Factor X Roma: a congenital factor X variant defective at different degrees in the intrinsic and the extrinsic activationV De Stefano, G Leone, R Ferrelli, et al.
Pageof 16